Anticoagulation strategies in COVID-19 infected patients receiving ECMO support

Anticoagulation strategies in COVID-19 infected patients receiving ECMO support

Background: Hospitalized COVID-19 patients with hypoxemic respiratory failure may deteriorate despite invasive mechanical ventilation and thus require extracorporeal membrane oxygenation (ECMO) support. Unfractionated heparin (UFH) is the antithrombotic of choice, however, bivalirudin may offer more...

Full description

Bibliographic Details
Main Authors: Diaz Dayne, Martinez Jenny, Bushman Grant, Wolowich William R.
Format: Article
Language:English
Published: EDP Sciences 2023-09-01
Series:The Journal of ExtraCorporeal Technology
Subjects:
ecmo
covid
anticoagulation
bivalirudin
heparin
Online Access:https://ject.edpsciences.org/articles/ject/full_html/2023/03/ject230023/ject230023.html

Internet

https://ject.edpsciences.org/articles/ject/full_html/2023/03/ject230023/ject230023.html

Similar Items